IRIS UniCatt

Rapaccini, Gian Ludovico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.306
EU - Europa 8.055
AS - Asia 7.969
SA - Sud America 1.487
Continente sconosciuto - Info sul continente non disponibili 375
AF - Africa 209
OC - Oceania 18
Totale 29.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.980
SG - Singapore 3.682
DE - Germania 2.768
CN - Cina 1.932
SE - Svezia 1.381
BR - Brasile 1.210
IT - Italia 780
FR - Francia 700
VN - Vietnam 682
UA - Ucraina 594
IE - Irlanda 427
GB - Regno Unito 409
FI - Finlandia 278
IN - India 272
JP - Giappone 263
ID - Indonesia 261
RU - Federazione Russa 181
TR - Turchia 169
CA - Canada 159
BD - Bangladesh 140
HK - Hong Kong 124
PL - Polonia 122
AR - Argentina 109
IQ - Iraq 73
MX - Messico 71
NL - Olanda 67
BE - Belgio 60
KR - Corea 58
ZA - Sudafrica 58
AT - Austria 56
ES - Italia 51
EC - Ecuador 44
SA - Arabia Saudita 43
CI - Costa d'Avorio 37
MA - Marocco 32
PH - Filippine 32
CZ - Repubblica Ceca 31
PK - Pakistan 30
VE - Venezuela 30
CO - Colombia 27
LT - Lituania 26
CH - Svizzera 25
UZ - Uzbekistan 25
AE - Emirati Arabi Uniti 21
IR - Iran 21
CL - Cile 19
RO - Romania 19
EG - Egitto 18
KE - Kenya 18
JO - Giordania 17
EU - Europa 16
BZ - Belize 14
PE - Perù 14
AU - Australia 13
AZ - Azerbaigian 13
BG - Bulgaria 12
CR - Costa Rica 12
IL - Israele 12
JM - Giamaica 12
PY - Paraguay 12
TW - Taiwan 12
UY - Uruguay 12
HN - Honduras 11
NP - Nepal 11
PT - Portogallo 11
DZ - Algeria 10
TT - Trinidad e Tobago 10
GR - Grecia 9
KZ - Kazakistan 9
PA - Panama 9
HU - Ungheria 8
KG - Kirghizistan 8
LB - Libano 8
TN - Tunisia 8
ET - Etiopia 7
MY - Malesia 7
SV - El Salvador 7
BY - Bielorussia 6
LK - Sri Lanka 6
NI - Nicaragua 6
OM - Oman 6
AL - Albania 5
BO - Bolivia 5
CG - Congo 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GE - Georgia 5
NZ - Nuova Zelanda 5
MD - Moldavia 4
SC - Seychelles 4
SY - Repubblica araba siriana 4
BB - Barbados 3
GY - Guiana 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
NO - Norvegia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 29.017
Salva come PNG Salva come JPEG
Città #
Singapore 2.038
Chandler 1.208
Ashburn 1.188
San Jose 1.008
Dublin 425
New York 414
Dallas 408
Beijing 333
Jacksonville 327
Los Angeles 270
San Mateo 250
Ho Chi Minh City 246
Tokyo 241
Jakarta 234
Nanjing 231
Hefei 228
Lauterbourg 217
Ann Arbor 163
Nürnberg 162
Boston 161
Wilmington 160
Hanoi 156
Houston 150
Frankfurt am Main 144
Dearborn 139
Munich 135
Chicago 130
Helsinki 128
The Dalles 128
Princeton 125
Milan 123
Rome 123
Moscow 113
São Paulo 106
Izmir 103
Hong Kong 100
Marseille 100
Cattolica 87
Tukwila 82
Buffalo 81
Santa Clara 80
Woodbridge 79
Boardman 78
Seattle 76
Nanchang 69
Kent 67
Bremen 61
Redwood City 61
Redmond 60
Brussels 55
Paris 55
Fairfield 53
Seoul 53
Kraków 52
Atlanta 51
Warsaw 50
Brooklyn 48
London 48
Shenyang 47
Denver 46
Montreal 45
Council Bluffs 44
Da Nang 44
Phoenix 42
Lawrence 41
Nuremberg 41
Toronto 41
Rio de Janeiro 39
Guangzhou 38
Hebei 38
Abidjan 37
Chennai 37
Lancaster 37
Shanghai 37
Tianjin 37
Hangzhou 36
Orem 36
Stockholm 36
Hyderabad 35
Belo Horizonte 34
Mountain View 34
Norwalk 34
Zhengzhou 33
San Francisco 31
Vienna 31
Amsterdam 30
Kunming 30
Pune 30
Baghdad 29
Poplar 29
University Park 29
Changsha 28
Johannesburg 28
Augusta 27
Bologna 27
Las Vegas 27
Manchester 27
Turku 27
Brasília 24
Haiphong 24
Totale 14.708
Salva come PNG Salva come JPEG
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 457
Association between Klinefelter syndrome and focal nodular hyperplasia 340
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 289
Acute hepatitis associated with use of paroxetine 284
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 279
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 265
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 250
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 250
Focal ultrasound lesions in cirrhotic liver diagnosed as regenerative nodules by biopsy. A morphometric analysis 249
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 241
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 240
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 239
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 230
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 224
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 211
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 209
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 208
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 204
recurrent acute hepatitis associated with use of cetrizine 202
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 201
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 193
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 192
Liver transplantation in patients with alcoholic liver disease: A retrospective study 192
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 191
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 190
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 189
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 189
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 179
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 179
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 179
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 179
Potential use of liver function breath tests in the clinical practice. 178
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 177
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 175
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 174
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. 174
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 172
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 171
Sarilumab use in severe SARS-CoV-2 pneumonia 170
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 169
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 169
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 165
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 165
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 161
Immunological role of IgG subclasses 161
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy 161
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 159
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 159
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 158
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 157
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 156
Development and validation of predictive assessment of complicated diverticulitis score 156
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 154
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 153
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 151
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 151
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 150
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 149
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 149
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 149
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 149
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 148
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 147
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 146
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 143
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. 142
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 142
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 142
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (< 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging 142
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 141
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 140
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 139
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 139
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 138
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 138
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 137
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 137
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 137
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 137
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 135
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 135
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 135
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 134
[Liver transplantation] 134
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 134
The role of elastography in non-Alcoholic fatty liver disease 134
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 133
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 132
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 132
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 131
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 131
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 130
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 128
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 128
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 128
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation 126
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 126
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 126
Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt 125
Totale 17.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.634
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.532 0 118 39 140 102 54 34 221 66 107 283 368
2022/20233.728 476 436 268 501 295 431 226 314 444 97 163 77
2023/20242.063 114 554 64 135 80 353 113 88 26 125 160 251
2024/20254.010 108 107 377 117 344 166 107 220 579 354 848 683
2025/202610.709 1.520 289 919 1.303 1.829 546 1.786 510 658 713 404 232
2026/20271.013 371 642 0 0 0 0 0 0 0 0 0 0
Totale 29.419